Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1734830 | 0.82 | P2RX7 (0.39) | P2RX7MEN1KMT2AEPHX2 | |
| SCHEMBL2830096 | 0.81 | P2RX7 (0.38) | P2RX7MEN1KMT2AEPHX2 | |
| SCHEMBL3010091 | 0.78 | — | — | |
| SCHEMBL2011441 | 0.75 | — | — | |
| SCHEMBL3000346 | 0.74 | P2RX7 (0.34) | P2RX7MEN1KMT2AEPHX2 | |
| SCHEMBL1735054 | 0.73 | P2RX7 (0.32) | P2RX7MEN1KMT2AEPHX2 | |
| SCHEMBL727665 | 0.73 | CYP2D6 (0.44) | MEN1KMT2AEPHX2 | |
| SCHEMBL1734016 | 0.72 | P2RX7 (0.35) | P2RX7MEN1KMT2AEPHX2 | |
| SCHEMBL289717 | 0.71 | OPRK1 (0.42) | P2RX7MEN1KMT2AEPHX2 | |
| SCHEMBL2170720 | 0.71 | P2RX7 (0.32) | P2RX7MEN1KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022799-A1 | CARBONYLATION OF CONJUGATED DIENES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022799-A1 | CARBONYLATION OF CONJUGATED DIENES | CBR3, CBR1, CA5B | P2RX7 1127/4885MEN1 2774/4885KMT2A 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.